Markets
Apnimed Completes Expanded $220.8 Million IPO on Nasdaq
Apnimed has successfully completed an expanded Initial Public Offering (IPO) on the Nasdaq exchange, raising $220.8 million. This operation signifies substantial capitalization for the company, providing resources for its growth strategy.
Carlos "Emérito" López Lovera
